Results 161 to 170 of about 11,461 (257)

Risk of re‐operation after Bascom I for pilonidal sinus disease. A Danish population‐based cohort study

open access: yesColorectal Disease, Volume 28, Issue 6, June 2026.
Abstract Background The treatment of chronic pilonidal sinus disease (PSD) is controversial. Minor PSD can be treated minimally invasively. The preferred minimally invasive treatment in Denmark is the Bascom I procedure. Aim To evaluate re‐operation rates following elective Bascom I and to identify potential risk factors.
Ida Kaad Faurschou   +2 more
wiley   +1 more source

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 963-979, June 2026.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault   +51 more
wiley   +1 more source

Hidradenitis suppurativa- retinoid therapy

open access: yes, 2009
Aim: Hidradenitis suppurativa is a chronic disease which affects areas bearing apocrine sweat glands and hair follicles. Pathogenesis of this disease is still unknown and it presents a huge social and therapeutic problem.Case report: A 43-year-old male ...
Gregurek-Novak, Teodora   +3 more
core  

New Hidradenitis Suppurativa in Children: Influence of Neighborhood Socioeconomic Status. [PDF]

open access: yesPediatr Dermatol
Sanchez-Anguiano ME   +6 more
europepmc   +1 more source

Building the foundations for an international patient‐centred outcomes set for psoriasis: A scoping study

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 1005-1018, June 2026.
This scoping study refined the first patient‐centred outcome set for psoriasis, involving patient representatives and dermatologists from 22 countries. The proposal includes 18 patient‐relevant outcomes, 2 patient experiences, corresponding outcome measurement instruments and 50 case‐mix variables.
Emma Vyvey   +35 more
wiley   +1 more source

Evaluation of Serum Zonulin Levels and Intestinal Permeability in Hidradenitis Suppurativa Patients

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Hidradenitis Suppurativa (HS) is a chronic inflammatory skin disease. Zonulin is a signaling protein secreted by enterocytes that regulates the function of tight junction complexes and intestinal permeability. The levels of zonulin increase in the blood with the disruption of the intestinal barrier and it is used as a biomarker ...
Elif Çetinkaya   +7 more
wiley   +1 more source

Hidradenitis Suppurativa-An intractable Dermo- Surgical Disease

open access: yes, 2012
Background: To study the surgical managementoutcome of Hidradenitis suppurativaMethods: In this descriptive study, patients presentingwith Hidradenitis suppurativa were analyzed withreference to presentation and surgical managementoutcome.Results: Out of
Muhammad Ateeq , Shazia Jehan
core  

Addictions in Hidradenitis Suppurativa: A Cross-Sectional Pilot Study. [PDF]

open access: yesDermatol Ther (Heidelb)
Böhner A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy